Sotera Health reported a 10% increase in net revenues to $249 million for Q3 2022, with net income at $25 million, or $0.09 per diluted share. Adjusted EPS improved to $0.23. The company is adjusting its full-year 2022 net revenue growth outlook to 7% - 8% and Adjusted EBITDA growth to 4% - 6%.
Net revenues for Q3 2022 increased by 10% to $249 million compared to Q3 2021.
Net income for Q3 2022 was $25 million, or $0.09 per diluted share.
Adjusted EBITDA for Q3 2022 increased by 7% to $125 million compared to Q3 2021.
Adjusted EPS for Q3 2022 improved to $0.23, up from $0.21 in Q3 2021.
Sotera Health is updating its 2022 outlook with net revenues expected to be in the range of $995 million to $1.005 billion and Adjusted EBITDA in the range of $500 million to $510 million.
Visualization of income flow from segment revenue to net income